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ABSTRACT
Background: By 2050, 27 million people will need some type of long-term care service, most of
whom will have multiple chronic diseases. Longer life spans and aging baby boomers will
double the population of Americans aged 65 years or older during the next 25 years to about 72
million. Since two out of every three older Americans have multiple chronic conditions, longterm care and end-of-life (EOL) care is going to continue growing as a significant healthcare
burden. Palliative care, particularly home-based palliative care, can help to reduce healthcare
costs at the end of life.
Purpose/Approach: This review seeks to examine literature surrounding home-based palliative
care in terms of 1) clinical effectiveness, 2) cost, 3) cost-effectiveness, 4) quality of life and
patient satisfaction, and 5) recommendations for healthcare policy and practices. Research
articles were found through a comprehensive search of PubMed and GlobalHealth (EBSCO)
databases. A policy brief will be included which will describe the aging population and the
burden on the U.S. healthcare system, opportunities for home-based palliative care, and policy
recommendations.
Review of Literature: Evidence shows that home-based palliative care compared to palliative
care in other environments may result in fewer hospitalizations, fewer hospital days, fewer ED
visits, and fewer physician office visits. Home-based palliative care reduces the likelihood of
readmission to a hospital within 30 days and increases the likelihood of completing an advanced
directive. It has shown to be cost-effective and result in lowered spending at a healthcare system
and an individual level. Home-based care patients and their families report high levels of quality
of life and satisfaction with their care.
Recommendations: A primary obstacle is the financial burden for patients since many insurers,
public and private, do not cover home-based palliative care. A barrier related to getting timely
access to palliative care is physicians and other healthcare staff not initiating conversations
around palliative care or EOL issues. Recommendations that will help remove barriers to care
include revising the Medicare hospice benefit to have less restrictive eligibility for home-based
care, providing incentives to healthcare providers for discussing and integrating palliative care,
and systematically training and educating health professionals on palliative care issues.
Conclusion: As the U.S. population continues to get older and suffer from multiple chronic
conditions, millions of people are going to require long-term care. Healthcare spending is also
going to continue to increase among the elderly and sick. Ensuring affordable and timely homebased palliative care to this population is a critical step in reducing healthcare costs and
improving quality of life.
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CHAPTER 1: INTRODUCTION
It is estimated that by 2050, 27 million people will need some type of long-term care
service, most of whom will have multiple chronic diseases (Giovanni, 2012). Longer life spans
and aging baby boomers will double the population of Americans aged 65 years or older during
the next 25 years to about 72 million (CDC, 2013). Since two out of every three older Americans
have multiple chronic conditions, long-term care and end-of-life (EOL) care is going to continue
growing as a significant healthcare burden (CDC, 2013). Treating patients with advanced illness
at the end of life is costly and complex. Palliative care, particularly home-based palliative care,
can help to reduce healthcare costs at the end of life. Currently, Medicare beneficiaries must
choose between receiving treatment and receiving palliative care. Therefore many people who
could benefit from quality palliative care are not receiving it due to choosing treatment.
Palliative care is an essential service that should be accessible and affordable to anyone who
needs pain management and supportive care while living with chronic conditions or other
debilitating diseases.
By the year 2030, adults over 65 will account for about 20 percent of the population.
Americans are living longer into their 70s, 80s, and beyond. The percentage of Americans who
are ages 85 to 94 grew by 30 percent between 2000 and 2010 (Werner, 2011). The aging
population has wide-range implications for many facets of society, including the burden to the
healthcare system as more people are living with chronic diseases. During the past century, a
major shift has occurred in the leading causes of death for all age groups, including older adults,
from infectious diseases and acute illnesses to chronic diseases and degenerative illnesses (CDC,
2013). Heart disease has been the leading cause of death since 1920 and cancer has been the
second leading cause of death since 1938 (CDC, 2013). These chronic conditions and others such
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as stroke, chronic lower respiratory disease, Alzheimer’s and diabetes pose the greatest risks to
older adults.
According to a 2012 CDC report, there were 133 million Americans who had at least one
chronic disease, and nearly 25 percent of those with a chronic disease had limitations in their
activities of daily living. People with chronic diseases often have other health problems like
substance abuse or addiction disorders, mental illness, dementia, or developmental disabilities.
Those with multiple chronic conditions face an increased risk of unnecessary tests, adverse drug
effects and avoidable hospitalizations (CDC, 2013). Long-term care is needed for many older
adults who suffer from multiple chronic conditions. Treating chronic illnesses accounts for 66
percent of the country’s healthcare budget and these expenditures are expected to continue to
rise. Medicare spending alone is expected to rise from $555 billion in 2011 to $903 billion in
2020 (CDC, 2013). Chronic conditions account for 95 percent of healthcare costs for older
Americans (CDC, 2013). Furthermore, the cost of providing healthcare for someone older than
65 is three to five times higher than the cost for someone younger than 65.
With the aging, sicker population, there is an increasing importance to consider EOL care
as an integral part of the healthcare system. Palliative care as a supportive service has expanded
and transformed in the U.S. and will continue to grow. Healthcare systems and payers must
increasingly respond to the increased demand of older adults with multiple chronic conditions
who need care both in a healthcare setting as well as in their home. Due to the growing demand
of supportive care for people who need pain management and enhanced quality of life, there
should be an option to receive affordable home-based palliative care. However, there are too
often barriers to receiving this care.
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There is evidence that home-based palliative care can reduce the cost of care, as well as
provide higher quality of care. This article reviews the literature on home-based palliative care
based on its results in terms of clinical effectiveness, cost, cost-effectiveness and quality of life,
and recommends policies and practices to ensure affordable and timely care.

DEFINING PALLIATIVE CARE AND THE GROWING NEED
The World Health Organization (WHO) provides a definition of palliative care:
Palliative care is an approach that improves the quality of life of patients and their
families facing the problems associated with life-threatening illness, through the
prevention and relief of suffering by means of early identification and impeccable
assessment and treatment of pain and other problems, physical, psychosocial and
spiritual.
Longer life expectancies, changing illness trajectories and advances in medical
technology have changed the historical view of palliative care (Meghani, 2004). Palliative care is
distinct from hospice care or EOL care in that it is not solely for those who are dying, but for
those whom alleviation of suffering and improvement of quality of life are relevant goals
(Meghani, 2004). Instead of a focus solely on treating the illness or condition, palliative care
responds to the whole patient and family, accepting individual preferences, values and goals
(National Consensus Project, 2009). In other words, EOL care can be considered palliative care,
but palliative care is not necessarily EOL care.
Palliative care provides an “extra layer of support that can be provided alongside diseaseoriented treatments” (Hughes & Smith, 2014). Patients who need palliative care include those
with chronic conditions, serious acute illnesses, longer-than-anticipated length of stay, or those
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experiencing major complications (Verret & Rohloff, 2013). An effective palliative care program
fosters clear communication among clinicians, patients, and families, as well as establishes and
focuses on clear patient care goals (Verret & Rohloff, 2013). As this paper will showcase,
effective palliative care programs have demonstrable measures of public benefit, including cost
savings, increased patient satisfaction and reduced hospital length of stay.
Palliative care expands traditional disease-model medical treatments to include the goals
of enhancing quality of life, optimizing function, helping with decision making, and providing
opportunities for personal growth (Snapp, 2010). It affirms life by supporting patient and family
goals, including hope for cure or life-prolongation, as well as hope for peace and dignity through
the course of illness, the dying process and death. Comprehensive and patient-centered care
manages pain and other symptoms, as well as incorporates psychosocial and spiritual care
(Snapp, 2010).
The need for palliative care is going to grow substantially in the next decades. From 2000
to 2010, more than 1,000 new hospital-based palliative care programs have been created (Hughes
& Smith, 2014). In 2000, 25 percent of large U.S. hospitals had a palliative care team, compared
with 66 percent in 2010. However, palliative care continues to be too often unknown,
underutilized or misunderstood (Verret & Rohloff, 2013).
There is a major opportunity for palliative services in the U.S. to be offered in the
patient’s home. Most people prefer to receive care in one’s home as opposed to a nursing home
or hospital due to the familiar surroundings of home and community (Panasci, 2009). In this
environment, the patient would have less opportunity for exposure to infectious agents and the
sole attention of the caregiver.
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BARRIERS TO PALLIATIVE CARE ACCESS
There are problems with insurance coverage for some who seek home-based palliative
care. For instance, Medicare is an acute-level insurer and will only cover home care if the
patient’s condition requires short-term or intermittent care (Panasci, 2009). Palliative care, on the
other hand, may continue for an unknown amount of time until the patient improves or passes
away.
Anecdotal evidence has described the struggle of some who have wanted to have care at
home instead of the hospital, but barriers would not allow it. One New York Times article (2014)
describes the story of Joseph Andrey who had been discharged to a nursing home over and over
again, but would not be allowed to go home because neither Medicaid nor Medicare would cover
home care. For-profit hospice companies only agreed to provide home visits if the doctor
certified that Mr. Andrey only had six months to live.
In the New York Times article (2014), Dr. Joan Teno, a gerontologist and author of
“Dying in America” says: “We have these frail older people moving about in the medicalindustrial complex that we’ve constructed. It’s all about profit margins. It’s not about caring for
people.” Teno (2013) found that most Medicare beneficiaries over the age of 65 received
treatment in a hospital in their last days and this percentage has increased since 2000. Transfers
of older patients among facilities and home have steadily increased since 2000. Also, only about
one third of Medicare beneficiaries die at home (Teno, 2013).
According to the Centers for Medicare and Medicaid’s (CMS) (2013) definition of
Medicare benefit, hospice is restricted to patients with a terminal illness with a prognosis of six
months or less to live who agree to forego “curative” care. Bonebrake et. al. (2010) describes
barriers around physicians initiating palliative care discussions and patients who may seek
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palliative care but fear doctors and loved ones will think they are “giving up” or seeking to
forego treatment. There is a need for people at high risk of death and disease, but are not eligible
or not interested in hospice. For instance, Bonebrake et. al. (2010) describes a case study in
which a man with prostate carcinoma was provided palliative care consultation for pain
management and supportive care. He did not have a prognosis of six months or less to live but he
did need his symptoms and pain managed. Home-based palliative care can be an important
option in these situations.
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PURPOSE
This review seeks to examine literature surrounding home-based palliative care in terms
of 1) clinical effectiveness, 2) cost, 3) cost-effectiveness, 4) quality of life and patient
satisfaction, and 5) recommendations for healthcare policy and practices. The research will
determine whether home-based palliative care is a viable option worth pursuing and making
policy changes. This will influence whether patients should have equal opportunities for homebased palliative care and other types of palliative care. A policy brief will be included which will
describe the aging population and the burden on the U.S. healthcare system, opportunities for
home-based palliative care, and policy recommendations.
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APPROACH
This capstone reviews the literature on home-based palliative care in terms of clinical
effectiveness, cost-effectiveness and quality of life of the patient and family. The body of
research will inform policy and practice recommendations that will help ensure affordable and
timely home-based palliative care to those who need it. Research articles were found through a
comprehensive search of PubMed and GlobalHealth (EBSCO) databases. The databases included
Medline, CINAHL, PAIS International, Web of Science, Cochrane Library, and Academic
Search Complete. Articles found through the databases were peer-reviewed and written in the
English language. The EBSCO disciplines searched were “Complementary and Alternative
Medicine,” “Consumer health,” “Health & Medicine,” “Psychology,” “Public Health,” and
“Social Sciences and Humanity.”
Search terms included “home-based,” “palliative or hospice,” “effectiveness” or “cost” or
“cost-effectiveness” or “quality of life” or “satisfaction.” Articles searched were published
between January 2003 and January 2015. All articles that referred to home-based palliative care
were reviewed. Articles that compared home-based palliative care to other types of palliative
care were included but not a requirement for inclusion. Due to the limited number of U.S. based
studies, articles from other developed countries similar to the U.S. were included. Commentaries
on home-based palliative care were reviewed for background information. Gray literature
produced by government agencies was also included.
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CHAPTER 2: REVIEW OF LITERATURE
CLINICAL EFFECTIVENESS
In general, palliative care has been shown to produce many clinical benefits including
quality of life improvement, better quality of care with less aggressive EOL care, and less
emotional distress (Hughes & Smith, 2014). This section of the literature review will describe
studies related to the effectiveness of palliative care in general, as well as outpatient palliative
care. Additionally, it will describe the clinical effectiveness of home-based palliative care based
on the following indicators: 1) hospital and emergency department (ED) visits, 2) place of death,
3) completion of advance directives, 4) symptom management, and 5) readmission rates.
There have been several studies demonstrating the possible prolongation of life with the
use of palliative care or hospice. For example, Verret & Rohloff (2013) describe a Massachusetts
study that followed patients with lung cancer who received palliative care along with standard
treatment, and patients who had standard treatment only. They found that although the palliative
care patients received less aggressive EOL care than the standard care patients, the palliative care
patients lived an average of 2.7 months longer (Verret & Rohloff, 2013).
There has also been some evidence of effectiveness in outpatient palliative care. For
instance, Scheffey et. al. (2013) showed patients in clinic-based outpatient palliative care had, on
average, longer length of stays at hospice than patients who did not receive palliative care. This
indicates that the patients were living longer while in hospice. There is less evidence of the
effectiveness of home-based palliative care in comparison to inpatient palliative care, but the
evidence is nonetheless important in showing that home-based care can actually offer improved
benefit over standard care.
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Hospital and ED visits
Research shows that hospital visits, hospital utilization and ED visits are reduced when
home-based palliative care is used. Lukas et. al. (2013) sought to evaluate a single, home-based,
non-hospice, palliative medicine consultation practice that was fee-for-service. The particular
practice called Optimizing Advanced Complex Illness Support (OACIS) serves patients with a
variety of diseases regardless of their specific prognosis or utilization of curative treatments.
Patients are seen in homes or assisted-living facilities, but not skilled nursing facilities. The
purpose of each visit was to improve symptoms and coordinate care, while also reconciling
patient and family expectations and plans with the actual illness severity (Lukas et. al., 2013).
Researchers evaluated hospital and ED visits and costs with a pre-post, single-patient group
design. The longitudinal analyses indicated that there were significant reductions in hospital
utilization after the 18-month study period, including number of hospitalizations and total
hospital days. There was no change in the probability of an ED visit. While causality cannot be
claimed, the results are encouraging given the emerging interest in home-based palliative
medicine.
The primary limitation of Lukas et. al. (2013) was the absence of a randomized control
design. The referral to a palliative medicine service may reflect selection bias and factors that
determine referral were not measured. Authors also only had access to hospital utilization data
from one healthcare network. Regardless, the article suggests that this delivery model can bring
palliative services to patients much earlier in the illness trajectory than currently possible with
hospice.
The next study shows less hospital use and fewer ED visits for the palliative care group
compared to a usual care group. Brumley et. al. (2003) was conducted at the Home Health
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Department at Kaiser Permanente in southern California between March 1999 and August 2000
to compare patients enrolled in a palliative care intervention to those receiving usual care. The
Palliative Care Program at Kaiser Permanente is an interdisciplinary home-based system of
healthcare designed to provide treatment to enhance comfort and improve the quality of a
patient’s life. The patients could decide to continue restorative treatment while also receiving
symptom control, patient education, and psychosocial services. The comparison group receiving
“usual care” was treated for conditions and only received home care when they met the
Medicare-certified criteria of an acute condition.
Data were collected from patient interviews and from the Kaiser Permanente service
utilization database. During the two year study, 300 patients were included in the sample.
Hospital and ED visits were significantly lower for the palliative care group than comparison
group patients. Comparison group patients had twice as many ED visits and four times as many
hospital days than the palliative care group. The palliative care group also had lower physician
office visits and less skilled nursing use (Brumley et. al., 2003).
Brumley et. al. (2007) completed a randomized, control trial in order to compare standard
care with an in-home palliative care program, specifically in the programs’ ability to improve
patient outcomes. The trial was conducted at two managed care sites in Hawaii and Colorado.
The patients were those who had 12 months or less to live and had visited the ED or hospital at
least once within the previous year. When referred to the program, they were randomly assigned
to standard care or in-home palliative care. The proportion of patients who died during the study
period was not significantly different between the study groups (Brumley et. al., 2007).
There were, however, significant differences between the groups in terms of service use,
with 20 percent of palliative care members going to the ED compared to 33 percent of usual care
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members. Furthermore, 36 percent of those receiving palliative care were hospitalized, compared
with 59 percent of those enrolled in usual care. After adjusting for survival, age, and severity of
illness, authors found that enrollment in the palliative care program reduced hospital days by
4.36 and ED visits by 0.35 (Brumley et. al., 2007).
Other developed countries have also analyzed the effects of home-based palliative care.
A population-based study from Spain compared ED admissions and inpatient days among cancer
patients in a geographic area with a palliative home care team and in an area without a palliative
home care team (Alonso-Babarro et. al., 2013). Authors found that the palliative care patients
used emergency services and inpatient services less frequently. The authors found that the use of
hospital resources during the last two months of life was significantly lower in the palliative
home care area (Alonso-Babarro et. al., 2013). However, a limitation is that the variations may
have been due to other regional differences not measured rather than whether the palliative home
care was located in that area.

Place of death
The place of death is an important indication of whether a patient’s wishes are met or not.
One narrative appraisal by Higginson et. al. (2013) looked at the science of dying at home. This
debate is increasingly relevant for all palliative care stakeholders and constitutes a public health
issue due to the rising numbers of deaths and increasing health expenditures. Preferences for
place of care and death show that home is the main preference, followed by hospice, but there is
a need for a greater understanding of factors underlying change of preferences and how often or
why these change over time. Kerr et. al. (2014) indicated that enrollment in home-based
palliative care may increase the likelihood of dying at home rather than in another setting.
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Brumley et. al. (2003) found that 90 percent of palliative care patients died in their home
compared to 57 percent of the comparison group patients. These findings remain significant even
after controlling for days of service and severity of illness. Limitations of Brumley et. al. (2003)
was the lack of a randomized controlled trial and the limited generalizability.
Brumley et. al. (2007) found that 71 percent of palliative care patients died at home,
compared with 51 percent of those receiving usual care. One limitation of the study was the
inadequate sample of individual minority groups, as well as limited generalizability since it was
conducted within a managed care setting (Brumley et. al., 2007). This study provides strong
clinical evidence supporting the provision of palliative care in the home of terminally ill patients.
Alonso-Babarro et. al. (2013) found in their Spain-based study that the frequency of
deaths in the hospital was significantly lower among patients in the geographic area with
palliative home care compared to the area without palliative care. The probability of a hospital
death increased in direct relationship with the number of visits to the emergency center or
inpatient hospital and with the number of inpatient days. The article is another piece of evidence
that improvements can be made in EOL care through public health policy and home deaths
should be an important part of the conversation.
There have been two systematic reviews on the effectiveness of home palliative care
services. A 2011 systematic review by Shepperd et. al. looked at four randomized controlled
trials to compare EOL care at home with inpatient or hospice care. Two trials were conducted in
the United States, one in Norway and one in the United Kingdom. In terms of place of death,
authors found that those receiving EOL home care were significantly more likely to die at home
compared with those receiving usual care, including hospice care, inpatient care and routinely
available primary healthcare (Shepperd et. al., 2011). A more recent 2013 systematic review by
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Gomes et. al. looked at studies of patients largely with advanced cancer but also congestive heart
failure and other chronic illnesses. Meta-analysis showed that home palliative care increased
odds of dying at home.
A better understanding of the factors influencing preferences for place of care and death,
including age, culture, social conditions or previous care experiences, could inform the model of
factors affecting place of death and contribute to the development of responsive palliative care
services and clinical practice (Higginson et. al., 2013).

Advance directives
Advance directives are important for ensuring that a patient’s EOL wishes are adhered to
in a time when the patient may not be able to communication for him or herself. Kerr et. al.
(2014) looked at the clinical impact of a home-based program through a hospice-private payer
partnership. Home Connections (HC) is a home-based palliative care program established in
Cheektowaga, New York in 2008. The HC team includes a palliative care-trained registered
nurse coordinator, social worker, trained volunteers, and a palliative care physician. Two local
private insurance payers support the program through a per member/per month fee. Referrals
come from physicians, palliative care agencies, local insurers, or the community. For this study,
administrative and clinical data were gathered retrospectively (Kerr et. al., 2014). Approximately
88 percent of HC patients had one or more completed advance directives, with 71 percent of
those without advance directives before enrollment subsequently completing them. This
indicates that home-based palliative care programs can increase the rate of actionable advance
directive completion.
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Symptom management
Another indicator of care effectiveness is the successful management of pain and other
symptoms. Kerr et. al. (2014) examined symptoms of patients in the palliative care group and the
usual care group. The average score for all symptoms (i.e. anxiety, appetite, depression, dyspnea,
nausea, pain, weakness, and well-being) improved during the first 10 weeks of enrollment in HC.
All of the symptom improvements were statistically significant, except those for depression and
pain. After the 10th week of enrollment, scores of all symptoms remained stable on average (Kerr
et. al., 2014). Results of this study showed that enrollment in home-based palliative care
appeared to result in multiple symptom improvement. A primary limitation of the study was the
retrospective design and absence of a comparison group (Kerr et. al., 2014).
In a 2011 systematic review by Shepperd et. al. did not find a difference between homebased and inpatient or hospice care in terms of patients’ functional status and psychological wellbeing or cognitive status. However, there was a difference in caregivers’ report of pain control
between the two groups and assessment of depression and anxiety. Caregivers in the home-based
care group reported less pain and less depression and anxiety (Shepperd et. al., 2011). A 2013
systematic review by Gomes et. al. found small but significant beneficial effects of home
palliative care services compared to usual care on reducing symptom burden for patients.

Readmission rates
An important component of clinical effectiveness is readmission rates. If home-based
palliative care services can reduce the 30-day readmission rate, they may have an important role
to play in post-acute care, particularly in Accountable Care Organizations (ACOs). Hughes &
Smith (2014) found that palliative care programs in general helped to reduce readmissions by 50
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percent. There is evidence that suggests home-based palliative care can reduce hospital
readmission rates as well. For instance, Lukas et. al. (2013) found that the probability of a 30-day
readmission was reduced after an 18-month study period of a home-based palliative care
practice.
One study was conducted in the University of Pennsylvania Health System post-acute
care program (Penn Homecare and Hospice Services) among patients who were admitted to a
home care program or a palliative home care program (Ranganathan et. al., 2013). The palliative
home program was staffed by hospice nurses rather than home care nurses, and had access to a
phone line that provides 24-hour access to a hospice nurse. An interdisciplinary team discusses
the palliative care patients biweekly, which is different than the standard home care group.
Researchers calculated the average treatment effect on treated patients, which is a measure of the
impact of palliative care on 30-day readmission, compared to what their readmission rates would
have been in the regular home care group (Ranganathan et. al., 2013). Results showed that
palliative care patients had a 30-day readmission probability of 9.1 percent compared to 17.2
percent in the home care group. Therefore, palliative home care programs may have the potential
to improve patient-centered outcomes by reducing readmission rates. More research may be
needed on how palliative care may reduce the 30-day readmission rate (Ranganathan et. al.,
2013).

COSTS
Not only do home-based palliative care programs need to be effective, but they should
not be more costly than other alternatives. Changes in Medicare reimbursement (i.e. 30-day
readmission policies) as well as the mandate through the 2010 Affordable Care Act that requires
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all people to have health insurance make it imperative for health systems to develop models that
reduce healthcare costs. One way to reduce healthcare costs is by delivering care in non-hospital
settings. Lukas et. al. (2013) found that reducing unnecessary hospital visits and treatments may
benefit hospital finances, even in a fee-for-service environment. This section provides evidence
that home-based palliative care programs are less costly than care in other settings in terms of
inpatient/ hospital costs, patient costs, and societal costs.

Inpatient/ hospital costs
There have been several articles that reviewed the costs of home-based palliative care.
Hughes & Smith (2014) found that palliative care programs helped to lower overall healthcare
costs by reducing the cost of inpatient stays and allowing each hospital to calculate the financial
savings from adding or expanding their palliative care team. The savings estimate is partly based
on reductions in inpatient length of stay, but it also includes savings from moving a patient from
a high-cost venue such as the intensive care unit (ICU) to a lower-cost setting such as usual or
palliative care—so called “cost avoidance.”
Morrison et. al. (2008) compared direct costs of patients who were cared for by a
palliative care team with direct costs of matched patients who were not covered by palliative
care. The study analyzed data from eight hospitals and found that the use of palliative care saved
an average of more than $7.5 million a year. This does not include indirect cost savings nor
savings from unwanted or unnecessary procedures which would make the cost savings even
greater. Savings included significant reductions in pharmacy, laboratory and intensive care costs
(Morrison et. al., 2008). The authors concluded that an average 400-bed hospital seeing 5,000
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patients a year could achieve annual net savings of $1.3 million by implementing a palliative
care program.

Patient costs
Brumley et. al. (2003) found that patients enrolled in the palliative care group had an
average $6,580 reduction in cost from the average cost for those in the comparison group
receiving usual medical care. Average cost of care for the comparison group was $14,570 and for
those in palliative care, the average cost was $7,990. Therefore, receiving palliative care reduced
medical costs of care by 45 percent.
Brumley et. al. (2007) completed a randomized, control trial to compare standard care
with an in-home palliative care program, specifically in the programs’ ability to reduce the costs
of medical care at the end of life. Authors found significant differences in the cost of care
between home-palliative care and standard care. The analysis revealed that overall costs of care
for those enrolled in the palliative care program were 33 percent less than those receiving
standard care. The average cost per day incurred by palliative care recipients ($95.30) was
significantly lower than that of usual care group members ($212.80). Authors concluded that
providing a palliative care team to homebound patients can have a positive effect in reducing
costs of care at the end of life.

Societal costs
A study out of Canada sought to examine the societal costs of home-based palliative care
and the socio-demographic and clinical factors that account for variations in costs over the
course of the palliative trajectory (Guerriere et. al., 2010). Patients were recruited from Mount
Sinai Hospital in Toronto and costs were assessed between time of admission and death.
22

Home-based palliative care

Behm

Caregivers were interviewed every two weeks. The Ambulatory and Home Care Record (AHCR)
was used to comprehensively measure costs of services from a societal perspective by
quantifying publicly financed care and private family costs. The majority of the sample reported
receiving both publicly funded medications and out-of-pocket medication costs. The average
monthly cost of care per patient was $24,549. Costs were higher closer to death compared with
time points more distant from death (Guerriere, et. al., 2010). One limitation of the report is that
the study relied on self-reports obtained through phone interviews. Also, the results may not
necessarily be generalized to people receiving services from other types of palliative care
programs. Lastly, approximate prices had to be used to derive the costs (Guerriere, et. al., 2010).
Another Canadian study analyzed the resource utilization and costs of a home-based
palliative care service over 15 months (Klinger et. al., 2013). The Niagara West End-of-Life
Care Project was designed to provide enhanced interdisciplinary home-based shared-care in a
rural community setting. The project collaborated with primary care teams and a palliative care
consultant or team. Most of the patients enrolled in the project had a cancer diagnosis, while a
few had advanced heart disease, chronic obstructive pulmonary disease, amyotrophic lateral
sclerosis, and Alzheimer’s. Frequently used services included specialized nursing, homemaking,
equipment rentals, and occupational and physical therapy. Most patients and families accessed
bereavement services, psycho-spiritual care and pain management.
The average length of stay in the program was 145 days. The total costs for all patientrelated services during the study were about $1,625,658 or $17,112 per patient (Klinger et. al.,
2013). A majority of the billing was for specialized nursing services, homemaking and
equipment charges. These costs were well within the parameters of the U.S. Medicare Hospice
Benefits and on par with the per diem funding assigned for long-term care homes. This is
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important because it indicates that home-based palliative care is not more expensive than hospice
or other long-term care facilities, and gives credence to the argument that Medicare benefits
should include home-based palliative care.
Limitations of this article include the relatively small number of study participants and
short timeframe that hamper generalizability. It was also a retrospective review using datasets
from one community hospital. Authors conclude that this analysis indicates that home-based
service provision is less costly than hospital-based alternatives (Klinger et. al., 2013). Future
projects should use economic analysis from the societal perspective in the study design from the
beginning to allow for comparisons across settings.

COST-EFFECTIVENESS
The literature in this section first examines the cost-effectiveness of palliative care in
general and reviews the cost-effectiveness of home-based palliative care. Most settings for
palliative care are shown to be cost-effective. Guerriere et. al. (2010) describes how
opportunities to improve the cost-effective allocation of palliative care services may be
calculated by comparing the incremental gains in satisfaction to the incremental cost of care over
the palliative trajectory, between care providers, and across alternative levels of service intensity.

Community-based palliative care
Higginson et. al. (2009) showed through a cost-effectiveness analysis based on the
Palliative Care Outcome scale and the Zarit Carer Burden Inventory, a caregiver self-report
measure, that the intervention group with palliative care had lower costs and better outcomes
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47.3 percent of the time, and higher costs and better outcomes 48 percent of the time. Therefore,
it was cost-effective about half of the time but always clinically effective.
Although not a home-based care program, one report describes the cost-effectiveness of a
palliative care program in a rural Alabama community hospital (McGrath et. al., 2013). The
average cost per day for the palliative care recipients was $754 and $1,027 for non-palliative care
recipients. Palliative care patients had a net savings of $273 per day. The palliative care cost
savings were calculated to be $148,471, which yielded a net cost savings of $46,971 (McGrath
et. al., 2013).

Home-based palliative care
The most rigorous cost-effectiveness analysis of home-based palliative care was a
prospective cost-effective analysis of the Palliative Care Extended Packages at Home (PEACH)
pilot randomized control trail in Sydney, Australia (McCaffrey et. al., 2013). Community care in
New South Wales is provided by a specialist palliative care team, general practitioners, and
community nurses. Patients enrolled in the PEACH trial had complex or unstable symptom
management and high care needs. Participants were randomized to receive PEACH or usual care.
Specialist palliative care services and PEACH costs were estimated using hourly rates of local
salaries, agency staff costs and equipment hire. Incremental net monetary benefit and costeffectiveness acceptability curves were estimated at potential threshold values for one extra day
at home.
PEACH participants had 13.1 average days at home, which was one more day than usual
care (McCaffrey et. al., 2013). PEACH costs varied widely with one high cost outlier attributable
to a large number of additional nursing hours. Of participants who died, 56 percent were in the
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PEACH pilot, and 80 percent were in usual care. The average direct cost associated with PEACH
was $3,489 per participants and was offset by $2,450 inpatient cost savings.
Authors found that the incremental net monetary benefit over 28 days for PEACH versus
usual care became positive when the threshold value for one extra day at home exceeded $1,068.
When the high cost outlier was removed, it reduced the threshold value to $846. The costeffectiveness acceptability curve indicates the probability of PEACH being cost-effective versus
usual care for potential threshold values for one extra day at home. Findings suggest home-based
palliative care can reduce hospitalizations and associated costs (McCaffrey et. al., 2013). More
research may be needed to determine if one extra day at home is meaningful to decision makers.
Limitations of the study include differences in baseline characteristics that may have been
associated with home deaths between intervention groups. Also, informal care costs were not
included and generalizability will be limited to care provided by similar costing and funding
models. Authors found that most of the costs of intensive, home-based care packages are offset
by reduced inpatient stays, while days at home are increased (McCaffrey et. al., 2013). These
findings provide great support for the financial feasibility of home-based palliative care
programs.

QUALITY OF LIFE & PATIENT SATISFACTION
The literature demonstrates that palliative care has implications for both patients and
families. It is important to see improved quality of life, relief of suffering, and the enhancement
of human dignity as a result of home-based palliative care. Families should also have improved
coping, less distress, and more support through the care process. The patient-family care
experience is of upmost importance for all palliative care services.
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Hospitals are in the business of healing, and there is a point where curative care is no
longer realistic (Verret & Rohloff, 2013). Healing is not just the curing of disease, but also
holistically addressing the physical, psychosocial, emotional, and spiritual wellness of a patient.
Palliative care provides a service to address the holistic care of patients and their families,
especially when chronic or severe conditions are not curable or resolvable (Verret & Rohloff,
2013). While palliative care can be administered in addition to curative treatment, many times it
is in lieu of curative treatment. This section will review literature showing that home-based
palliative care provides increased quality of life for patients and caregivers by looking at the
following indicators: 1) patient satisfaction, 2) patient symptoms, and 3) caregiver satisfaction.

Patient satisfaction
Studies of home-based palliative care consistently indicate higher quality of life and
patient satisfaction. Brumley et. al. (2003) compared the satisfaction of patients in the palliative
care group and comparison group when they enrolled and 60 days following enrollment.
Satisfaction with services was significantly higher in the palliative care group 60 days following
enrollment than at baseline (t= -2.57, p=0.01) while satisfaction remained the same for
comparison group members (t= -0.5, p=0.6) (Brumley et. al., 2003). Kerr et. al. (2014) found that
the patients, caregivers and physicians were consistently satisfied with the program throughout
the study.
Brumley et. al. (2007) conducted a randomized control trial among patients in two health
maintenance organizations in Hawaii and Colorado and there was no significant difference in the
portion of participants reporting to be very satisfied at baseline or at 60 days after enrollment.
Rates of satisfaction did increase in the intervention group at 30 days and 90 days after
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enrollment, with 93 percent of those enrolled in the palliative care group very satisfied with care
at 90 days after enrollment, compared with 81 percent of usual care patients. This indicates that
an in-home palliative care program plus usual care can increase patient satisfaction compared
with usual care alone (Brumley et. al., 2007).
Similarly, a Japanese day hospice was evaluated to determine advanced cancer patients’
quality of life and satisfaction with day hospice (Miyashita et. al., 2008). A cross-sectional
questionnaire was administered to patients cared for at day hospices or home palliative care
services. Compared to national standard values, the average physical component summary and
mental component summary was significantly lower in both the day hospice and home palliative
care service patients and caregivers. For eight of the 11 questions, 70 percent or more patients
were satisfied. Eighty percent of caregivers were satisfied about patient-related items and
caregiver-related items (Miyashita et. al., 2008). Although advanced cancer patients and
caregivers have a lower quality of life compared to the general population, patients and
caregivers were mostly satisfied with the home palliative care based on this article.

Patient symptoms
Peters and Sellick (2006) describe the quality of life of cancer patients receiving inpatient
and home-based palliative care. Authors compared the symptom experience, physical and
psychological health status, level of personal control over the illness, and quality of life of
patients in both groups. Symptoms were assessed using the Memorial Symptom Assessment
Scale (MSAS), a self-report instrument. Physical health was assessed using the Palliative
Performance Scale (PPS) and the Hospital Anxiety and Depression Scale (HADS) was used to
indicate anxiety and depression.
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The most prevalent symptoms (more than 70 percent) reported by the inpatient group
were weakness, fatigue, dry mouth, sleeping during the day, and pain. The least prevalent
symptoms (less than 20) were mouth sores and weight gain. For home-based patients, fatigue,
pain, weakness and ﬂatulence were the most prevalent and diarrhea, headache, mouth sores and
weight loss were the least prevalent symptoms (Table 1). Higher average scores were recorded
for the inpatient group on all four symptom measures (Peters & Sellick, 2006).
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Table 1- Peters & Sellik, 2006

Symptom prevalence for inpatient and home-based groups (ranked for inpatient patients)
Inpatient
Home-based
n
%
n
%
Symptom
Weakness
28
87.5
18
69.2
Fatigue
27
84.4
21
80.8
Dry mouth
24
75
17
65.4
Sleeping during the day
24
75
15
57.7
Pain
23
71.9
20
76.9
Lack of appetite*
21
65.6
10
38.5
Flatulence
19
59.4
18
69.2
Thirst
18
56.3
11
42.3
Belching*
17
53.1
7
26.9
Nausea
16
50
12
46.2
Diarrhoea**
15
46.9
3
11.5
Constipation
15
46.9
12
46.2
Shortness of breath
14
43.8
14
53.9
Taste alteration
13
40.6
10
38.5
Vomiting
12
37.5
7
26.9
Sweating
12
37.5
8
30.8
Dizziness
11
34.4
6
23.1
Weight loss
11
34.4
5
19.2
Cough
9
28.1
11
42.3
Swelling of arms/legs
9
28.1
11
42.3
Bad taste
9
28.1
11
42.3
Headache
8
25
4
15.4
Itchy skin
7
21.9
9
34.6
Weight gain
5
15.6
6
23.1
Mouth sores
4
12.5
4
15.4
*P < 0.05; **P < 0.01

Results showed that home-based patients had statistically signiﬁcantly higher physical
health scores for physical status and lower depression scores. Although not statistically
signiﬁcant, the home group also scored higher on the PPS and lower on the anxiety scale. The
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home-based group scored signiﬁcantly higher on all personal control measures (control over
daily symptoms, control over the course of the illness, and control over medical care and
treatment). Both groups scored higher on “personal control over symptoms and medical care”
and “treatment” than on “the course of the disease” (Peters & Sellick, 2006).
The impact of disease on quality of life was less for patients at home than those receiving
inpatient care on all measures. Although the two groups were similar on a number of measures,
patients receiving home-based palliative care tended to have better physical and psychological
health and quality of life. Home-based patients also experienced fewer adverse effects from their
symptoms and reported having more control over their illness and treatment (Peters & Sellick
2006). However, caution is needed when interpreting these ﬁndings given that a higher
proportion of patients in the home-based group were married, of Australian descent, had private
health insurance and were less likely to be living alone.
An Australian study compared the prevalence of anxiety and depression in palliative care
patients being treated at home with those being treated as inpatients (Austin et. al., 2011). HADS
was used to measure anxiety and depression symptoms in the patients. The Karnofsky
Performance Status Scale (KPS) was used as an indicator of functional status. The home-treated
patients and inpatients did not differ significantly in terms of average age or gender, but did
differ in functional status and socioeconomic status.
The groups did not differ significantly on HADS depression, anxiety or total scores
(Austin et. al., 2011). Younger age and lower KPS scores were associated with higher HADS
scores. About 20 percent of all the palliative care patients showed meaningful anxiety and
depression which underscores the importance of addressing psychological distress in palliative
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care services. Appropriate and equal staff resources should be used on palliative care inpatients
and those being treated at home.

Caregiver satisfaction
Within a larger article about cost variations in home-based palliative care, Guerriere et.
al. (2010) measured satisfaction of caregivers using the Quality of End-of-Life Care and
Satisfaction with Treatment (QUEST) scale. The majority of caregivers reported being either
very satisfied with the quality of care provided by physicians and nurses (71 percent and 60
percent, respectively) or satisfied (26 percent and 33 percent, respectively).
Guerriere et. al. (2013) used QUEST to interview family caregivers about their
satisfaction with home-based physician and nursing palliative care services. Satisfaction is
defined as the degree to which expectations of several aspects of care are met. The authors
designed a prospective, longitudinal cohort study that measured satisfaction with care from
admission until death. This particular palliative care program provides community
multidisciplinary care, including symptom management and practical/emotional support to
individuals at home 24 hours per day, 7 days per week. Study participants were interviewed
every two weeks and reported their perceptions of satisfaction over the previous two days.
A majority of the caregivers were female and were generally either spouses or children of
the patient (Guerriere et. al., 2013). Data from 748 interviews was analyzed and the majority of
interviews resulted in high satisfaction with both nursing and physician care. On five different
categories, caregivers reported being very satisfied with physician care (an average 87 percent) at
a higher rate than they did for nursing care (an average 71.2 percent). The categories included
bedside manner, common courtesy, way of talking to patient, clinical and technical skills in
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treating patient, and concern for patient as an individual (Table 2). Quality-of-care parameters
included questions about the provider spending enough time with the patient, arriving on time,
accessibility, attentiveness and personal concern. Authors found that quality-of-care parameters
are strong predictors of satisfaction (Guerriere et. al., 2013).
Table 2- Guerriere et. al. 2013

Caregivers' perceived satisfaction by scale items and professional category
Nurses (N= 274)
Doctors (N= 154)
n
%
n
%
Bedside manner
very satisfied
dissatisfied

199
75

72.6
27.4

137
16

89.5
10.5

very satisfied
dissatisfied

196
78

71.5
28.5

138
15

90.2
9.8

very satisfied
dissatisfied

191
83

69.7
30.3

136
17

88.9
11.1

Clinical and technical skills in treating
patient
very satisfied
dissatisfied

189
85

69
31

134
19

87.6
12.4

201
73

73.4
26.6

128
25

83.7
16.3

185
89

67.5
32.5

116
37

75.8
24.2

40
38
37
39

26
24.7
24
25.3

47
59
64
104

17.1
21.5
23.4
38

Common courtesy

Way of talking to patient

Concern for patient as an individual
very satisfied
dissatisfied
Overall satisfaction
very satisfied
dissatisfied
Months to death
0
1
2 to 3
4+
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Sociodemographic variables were not shown to be significant predictors of satisfaction.
The article demonstrates that healthcare providers should be meeting quality parameters, in part
to increase family caregivers’ satisfaction with home-based palliative care services. One
limitation of the study was not measuring the patients’ perceptions, only the caregivers’
perceptions. The results may not be generalizable to individuals receiving services at other types
of palliative care programs (Guerriere et. al., 2013).
Another article based in Australia sought to assess how family caregivers were supported
in three home-based palliative care services (Thomas et. al., 2010). Focus groups with health
professionals were conducted to determine what services were currently available for the
caregivers, how well the services met caregivers’ needs, and perceived barriers to supporting
caregivers. A file audit was also conducted to determine the frequency of actual support services
received by caregivers. Authors found that there were not formalized procedures for assessing
and responding to family caregiver needs in a comprehensive way (Thomas et. al., 2010).

SUMMARY
The existing literature suggests that home-based palliative care compared to palliative
care in other environments may result in fewer hospitalizations, fewer hospital days, fewer ED
visits, and fewer physician office visits. There is evidence that the probability of readmission to a
hospital within 30 days is less for home-based patients. The research also shows that those
receiving home-based care are more likely to die in their home, which is the preference for a
majority of people. Other positive benefits include a higher likelihood of completed advanced
directives by those receiving palliative care at home. Completing advanced directives improves
the chance that patients will receive life-saving care, or not receive care if desired, in times when
they are unable to speak for themselves.
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An ideal healthcare situation for a person with a chronic disease or debilitating condition
would be to have his or her treatment and palliative care options described by a team of
healthcare professionals, including an option for home-based palliative care. This option would
be presented once the healthcare team, patient and family agree that care can be adequately
managed at the home and a plan for curative care, or lack thereof, is understood by all parties.
Many articles suggest that home-based care may be the preferred option for patients who are in
better health, wish to remain independent, believe that they have control over the effects of their
illness and treatment, and who have supportive networks at home. Alternatively, inpatient care,
particularly in hospice, is the more likely choice for patients who are very ill or require intensive
symptom management, or where the family is unable to cope with the burden of care. If homebased care is chosen, it may be delivered integrally by a specialized palliative care team or
individual physicians and nurses, depending on the patient’s medical condition. Appointments in
the hospital or other healthcare settings can still be arranged at designated intervals or as needed
when testing or other follow-up services cannot be adequately performed in the home setting.
Several articles found that there was a cost reduction by bringing care to the home. Most
of the costs were derived from specialized nursing, homemaking, and equipment. Furthermore,
these home-based costs were found to be well within the parameters of the U.S. Medicare
Hospice Benefits. Therefore Medicare should cover beneficiaries’ home-based care costs at the
same level as hospice and inpatient settings. An incentive for covering home-based care through
government insurance is cost reduction, which may help to reduce overall U.S. healthcare costs.
Other cost-effectiveness articles found a net savings when people received care at home as
opposed to an inpatient setting. Home-based palliative care is an effective and encouraging
option for reducing healthcare spending.
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Quality of life and satisfaction was found to be favorable in home-based patients and
often times higher than inpatient patients and families. Various studies showed patient
satisfaction to be higher after 30 days of care, 60 days of care, and 90 days of care. Other
evidence showed high percentages of home-based patients who are very satisfied or satisfied
with physicians and nurses. Some results showed higher physical health and lower depression for
home-based patients. Home-based groups were also found to score higher on personal control
measures. Just as important as patient well-being is family and caregiver well-being. Research
presented evidence that families of home-based palliative care patients had high satisfaction with
physicians and nursing staff. The evidence indicates that wider availability and accessibility of
home-based palliative care would be highly valued by patients and families who want to spend,
in many cases, the end of the patient’s life together in the comfort of their own home.
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CHAPTER 3: RECOMMENDATIONS
This article presents important findings that suggest home-based palliative care can be
clinically effective, cost-effective and improve quality of life among patients and their families.
However, there are many barriers that prevent affordable and timely access to care. A primary
obstacle is the financial burden for patients since many insurers, public and private, do not cover
home-based palliative care. For instance, Medicare, one of the nation’s largest health insurers,
only provides the hospice benefit as an EOL option for patients. The current Medicare hospice
benefit only covers palliative and support services for patients designated to have a terminal
illness and a life expectancy of six months or less (CMS, 2013). The hospice benefit will not
cover treatment costs, room and board, care in an emergency room or inpatient facility, nor care
from any hospice provider not set up by the hospice medical team (CMS, 2013). By electing to
receive the benefit, patients forfeit any conventional treatment for the condition. This may feel to
the patient that they are “giving up” or resigning themselves to death. Due to the large number of
older adults suffering from multiple chronic conditions who could benefit physically and
psychosocially from supportive care, there should be insurance coverage for palliative care
without the requirement to have a terminal illness. When care is not covered by insurance, the
financial burden of paying for care out-of-pocket is so large that it is often unmanageable and
unrealistic.
A barrier related to getting timely access to palliative care is physicians and other
healthcare staff not initiating conversations around palliative care or EOL issues. This may be
due to the lack of incentives offered to healthcare professionals to initiate EOL conversations and
a lack of education around palliative care and when to discuss the topic. Doctors may feel that
they do not have enough time, resources, or knowledge to have these types of discussions with
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their patients and therefore do not initiate the conversation until it is too late to have any valuable
impact.
These following recommendations serve to limit barriers to affordable and timely homebased palliative care:
1. Medicare benefit should include home-based palliative care without the
requirement to forego treatment
Medicare should cover home-based palliative care similarly to the way Medicare covers
hospice benefits but without the requirement to be terminally ill, have six months or less to live,
and to forego treatment. The benefit would cover doctor services, nursing care, medical
equipment and supplies, prescription drugs, counseling and other care as described in the 2013
Medicare Hospice Benefits. Palliative care should be available for those patients who wish to
receive care at home, but may also want to continue getting life-saving treatment. Patients
should not feel forced to be in an inpatient setting to receive care that can be provided in the
home. The current Medicare hospice model does not address patients with multiple chronic
conditions and ambiguous prognoses. Research has shown that providing palliative care earlier
in the course of disease leads to better health outcomes, higher satisfaction with care and
reductions in healthcare costs (California HealthCare Foundation, 2013). It has also been shown
that there is considerable value in the concurrent delivery of palliative and curative care.
Calls have certainly been made to increase the availability of and access to palliative care
services in the U.S. healthcare system (Meier, 2011). Medicare beneficiaries are receiving care
that is fragmented and uncoordinated and does not take into account their overall care needs.
Evidence supports the need for fundamental changes in the design of the U.S. healthcare system
by adjusting our current hospice benefit to better meet the needs of patients or developing a new,
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‘‘pre-hospice’’ palliative care benefit that provides a bridge between standard medical care and
hospice care (Brumley et. al., 2007). For the past several years, policymakers have debated
reform of the Medicare hospice benefit, in terms of eligibility, financing, and structure
(MEDPAC, 2012). In 2009, Congress gave CMS the authority to revise the hospice payment
system. Since the CMS Secretary had not exercised that authority, the recommendation was
printed again in the 2014 Medicare Payment Advisory Commission (MEDPAC) report.
The 2010 Affordable Care Act (ACA) is requiring that data be collected by CMS
regarding hospice quality (MEDPAC, 2014). ACA mandates a three-year demonstration to test
the effect on quality and cost of allowing simultaneous hospice and conventional care. Through
the pilot Medicare Care Choices Model, CMS is providing an option for Medicare beneficiaries
to receive palliative care services from certain hospice providers while concurrently receiving
services provided by their curative care providers. CMS will evaluate whether providing hospice
services will improve the quality of life, increase patient satisfaction, and reduce Medicare
expenditures. The results of this study will be important for implications on how Medicare
hospice benefits are structured in the future.
Medicare is already spending about $15 billion on hospice a year and 34.5 percent of the
hospice patients receive a week or less of care (NHPCO, 2015). If home-based palliative care
was offered to those same patients earlier in their illness trajectory, costs could potentially be
avoided by reducing unnecessary care and managing high-need, “at risk” patients.
Medicare needs to replace the eligibility requirement for hospice benefits to include those
who have Medicare Part A and are certified by a physician as having an advanced or late-stage,
progressive or degenerative chronic illness in which the disease or physical ailment significantly
worsens, grows, or spreads over time. While a prognosis of six months or less to live is difficult
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to certify and should not be required, the illness should be considered “advanced”, cause a
significant amount of impairment to the patient’s daily activities, and require continuous medical
care, as determined by a primary healthcare provider. Examples of progressive disease would
include Alzheimer’s disease, cancer, chronic obstructive pulmonary disorder, Huntington’s
disease, multiple sclerosis, Parkinson’s disease and others as classified by the National Institutes
of Health.

2. Compensation to healthcare providers for discussing and integrating palliative care
The 2014 Institute of Medicine report, “Dying in America,” was released by a committee
of 21 experts that calls the U.S. EOL care system “broken” and recommends several ways to
improve care. One of the recommendations is reimbursing providers to discuss EOL care and
advance planning with their patients. Authors found that incentives under fee-for-service
Medicare result in increased use of medical services and late enrollment in hospice, which can
jeopardize the quality of EOL care and add to costs. Incentivizing provisions of comprehensive
palliative care and discouraging the use of costly and unnecessary medical procedures can
improve patient outcomes and reduce healthcare costs (IOM, 2014). The report recommends that
the federal government require public reporting on quality measures, outcomes and costs
regarding care near the end of life for programs like Medicare and encourage other healthcare
delivery systems to do the same. There should be financial incentives for medical services that
decrease the need for emergency room and acute care services, coordination of care across
settings and providers, and improved shared decision making and advance care planning (IOM,
2014).
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The 2013 MEDPAC report also recommends a Medicare payment to compensate
physicians or interdisciplinary teams for voluntary advanced care planning. This would help
incentivize quality care and working with the patient and family to carry out their wishes.
Advanced care planning may include discussions of where the patient would like to receive care
and for how long he or she would want to be treated. According to the Dartmouth Atlas Brief
(2013), Medicare spending in the last two years of life increased 15 percent between 2007 and
2010 from $60,694 to $69,947 per patient. Furthermore, Riley (2010) found that about 25
percent of the Medicare budget is spent on care during the last year of life. Nicholas et. al. (2011)
found that advance directives specifying limitations in EOL care were associated with lower
costs in regions were EOL spending was highest. The savings to Medicare due to reduced EOL
spending would help offset the cost of Medicare-financed incentives to healthcare providers.
Federal or state governments could subsidize incentives for private practice physicians
contingent on meeting quality standards.
Landers (2009) describes the Medical Home initiative using MEDPAC recommendations
as a concept that creates a way for primary care clinicians to receive payment for added care
coordination, care integration, quality improvement, and education activities for patients with
chronic diseases. The extra payments would be accompanied by added requirements and
accountability for outcomes. Providing compensation to physicians and other healthcare
providers for discussing palliative care options and coordinating care would increase the number
of patients who understand their care and treatment options.
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3. Better training for health professionals on palliative care topics
There needs to be improved training of health professionals on issues like patientcentered care and palliative care as a longer term approach in improving care for patients with
advanced illness. This training can be included in medical school curriculum, nursing school
curriculum, and other healthcare training curriculum. According to the 2014 MEDPAC report,
very short hospice stays are still common which indicates that patients enter hospice in the last
week or so of their life, unable to receive the full benefit of palliative care. This may be due to
physicians’ reluctance to have conversations about hospice or death, difficulty in some patients
and families to accept death, and financial incentives in the fee-for-service system which value
volume over quality (MEDPAC, 2014). Zhang et. al. (2009) found that patients who had an EOL
conversation with their doctor had 36 percent lower expenses compared to those who did not
have those discussions.
The IOM report (2014) recommends improving palliative care training among all
physicians. Educational institutions, credentialing bodies, accrediting boards, state regulatory
agencies and healthcare delivery organizations should establish appropriate training, certification
and licensure requirements to strengthen palliative care knowledge and skills of all physicians
who care for patients with advanced illness (IOM, 2014). Basic palliative care competencies
include communication skills, interprofessional collaboration and symptom management.
Certifying bodies should require competency in palliative care, and educational institutions and
professional societies should provide training throughout the professional’s career (IOM, 2014).
Other entities like healthcare delivery organizations, academic medical centers, and teaching
hospitals should increase the number of available training positions for specialty-level palliative
care.
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It is still engrained in the psyche of the American hospital system that healthcare
professionals should continue treating the patient until the last possible moment. Additional
training would help health professionals resist the idea that palliative care is the same thing as
hospice and should be reserved for those who have a short time to live. Training of healthcare
professionals needs to emphasize high-quality care and comfort of the patient, including homebased palliative care options and advanced care planning. Acknowledging advanced illness and
mortality provides an opportunity to deliver high standards of care, grounded in choice and
responsiveness to needs for both the patient and their family.
When palliative care is taught, results can be impressive. A systematic review by BickelSwenson (2007) found that EOL educational curricula and clinical training found in a wide range
of formats improved the competency of medical students. Authors found a 23 percent
improvement in knowledge, a 56 percent improvement in feelings of competence, and a 29
percent decrease in concerns. Improvements are already being made by several universities and
associations. For example, George Washington University includes a standardized patient case
on palliative care and a course on medical interviewing and decision making. The University of
Rochester includes content on advance care planning, chronic pain management, and discussion
of treatment goals. The Association of American Medical Colleges is in collaboration with the
Coalition to Transform Advanced Care to identify relevant core competencies.

CRITICISM
There was debate in 2009 related to Medicare paying physicians to discuss EOL care
with their patients, with critics calling them “death panels” out of fear that the physicians would
ration healthcare to elderly patients. Some believe that government payment for counseling on
EOL decisions would lead to more government regulation and oversight, and create a conflict of
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interest between the government’s fiscal needs and patients’ medical needs. As a result of the
controversy, the ACA did not include that piece of legislation. However, the 2014 IOM report
emphasizes that the important question related to EOL discussions is whether patients near the
end of their lives are getting the care they actually want. By reimbursing physicians to discuss
EOL care, patients can be more informed and empowered to make decisions on how to spend
their final days. Reimbursements should be tied to standards and quality measures so that the
quality of patient care would be improved, not diminished.
There are also politically conservative critics who oppose any additional funding to
Medicare, either to pay for additional benefits or for physician incentives. However, the research
indicates that offering home-based palliative care not only can improve the quality of life of a
vulnerable population, but can result in cost-savings at the individual and provider level.
Healthcare costs are high and rising in the United States, and improving accessibility and
affordability of home-based palliative care through Medicare is an opportunity to reduce EOL
costs throughout the country.
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CHAPTER 4: DISCUSSION
The aging of the American population is quickly expanding the healthcare burden, in
large part by the 66 percent of older adults who have multiple chronic conditions. Treating
advanced illness and chronic conditions in the older population is complex and expensive.
Medicare spending is expected to increase from $555 billion in 2011 to $903 billion in 2020. As
the U.S. healthcare system struggles to keep up with the demand for care, there will be an
increasing need for high-quality palliative care in all settings, but particularly home-based
settings. Home-based palliative care has been shown to be at least equally effective as inpatient
palliative care, less costly than inpatient care, and results in improved quality of life and patient
satisfaction. Therefore, patients and their families should have the choice to use home-based
palliative care when it is available, without the burden of financial or accessibility barriers.
Providing this home-based option will greatly alleviate the strain on inpatient settings and
will reduce hospital and patient costs. An approach toward high-quality care and coordination
and away from over-treating or inappropriately treating patients will improve quality of life as
well as reduce unnecessary medical costs. This is an opportunity that the U.S. healthcare system
and Medicare cannot afford to ignore. It is critical that federal, state, and local regulatory and
payment policies evolve to support the delivery of high-quality palliative care to a growing
elderly population who often live for many years with the burden of serious, chronic illnesses
(Unroe & Meier, 2013). Legislation needs to be passed to implement these policy changes.

SUCCESSFUL PROGRAMS & MODELS
There are opportunities for health systems to model home-based palliative care programs
after successful HMO programs like Kaiser Permanente and other ACOs. The Kaiser
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Permanente in-home program, offered as a standard benefit to most members, includes an
interdisciplinary team of providers who manage patient’s symptoms and pain, provide emotional
and spiritual support, and offer ongoing education about changes in the patient’s condition
(AHRQ, 2009). The patients do not have to forgo curative care in this program. Brumley et. al.
describes the evidence of a randomized controlled trial (2003) and a comparison-group study
(2007) which shows that Kaiser Permanente’s program increased patient satisfaction, increased
the portion of patients dying at home rather than in the hospital, and reduced ED visits, inpatient
admissions, and costs.
The Pioneer ACO Model is designed for healthcare organizations and providers that are
already experienced in coordinating care for patients across settings and allows them to move
from a shared savings payment model to a population-based payment model, similar to the
Medicare Shared Services Program (CMS, 2015). The model is designed to work in coordination
with private payers by aligning provider incentives, which will improve quality and health
outcomes among patients and achieve cost savings for Medicare, employers and patients (CMS,
2015). There are currently 19 ACOs participating in this model and being evaluated for
performance. This is an innovative example of changing payment models and providing
incentives for high-quality, coordinated care.
There are other ACO programs that can be adopted such as the Medicare Shared Savings
Program which helps Medicare fee-for-service providers become an ACO, and the Advance
Payment ACO model, which is a supplementary incentive program for selected participants in
the Shared Savings Program. As home-based palliative care is implemented in various healthcare
systems, there will be even more robust evidence to justify new practices offering this type of
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care. Furthermore, as more healthcare organizations use home-based palliative care, it would be
expected that insurance and payers will begin to cover these important services.

ADVANCING POLICY RECOMMENDATIONS
While policy recommendations are important, it is critical to understand the actions that
must be taken to ensure the guidance provided is utilized and implemented through policy
changes. An important first step is the engagement of all relevant stakeholders and participants
impacted by the recommended changes to the hospice payment system. Kingdon (1995) provides
a useful policy framework to inform efforts aimed at achieving policy change, suggesting a focus
on “three streams” of policymaking – problems, policies (i.e., solutions), and politics. Kingdon
suggests that if advocates can 1) help policymakers recognize their issue as an important
problem, 2) develop attractive and feasible policy solutions, and 3) catalyze broad support
among stakeholders that catalyzes political will, a policy window will open that allows for the
adoption of the desired policy.

Framing the problem
Efforts to frame the problem of lack of access to palliative care may benefit from
guidance from Stone (1989) who suggests that causal arguments can lead to agenda-setting in
politics. Stories framed in this manner can lead to emotional responses and increased support for
proposed policy solutions. Casual arguments place blame or responsibility of a problem on a
person or system and seeks to fix the problem through political means (Stone, 1989). An
example of a narrative that is emotional and defines the problem is from a response submitted
through the online public testimony questionnaire for the 2014 IOM report:
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“We got hospice when my mother-in-law died, but only for 2 weeks. She declined
steadily for 2 years before her death, as we bounced back and forth between hospital,
nursing home, and home (with private-paid caregivers). It was a bad way to go, with
much pain, suffering, and expense for her and our family. There were too many barriers
to getting the care she needed. Medicare pays for all types of care that is unbeneficial
(911 trips to the hospital, certain tests, treatments, medications, surgeries, and skilled
nursing home stays for rehab, etc.). But it will not pay for the care people actually need
during chronic, progressive illness—custodial care, comfort care, nursing care. We need
to fix this.”
This testimony is an example of a real problem that families of people at the end of their life face
every day. When palliative care for those with advanced chronic illness is not affordable because
insurance does not cover it and/or is not accessible because physicians do not discuss the
patient’s options, there is a major financial and emotional strain on families and caregivers.
Certifying six months or less to live is difficult for physicians since every illness progresses in
different ways and over various lengths of time. Furthermore, Riley (2010) found that 25 percent
of the Medicare budget is spent on care during the last year of life, which indicates large amounts
of money is being spent on life-saving treatments which may or may not be desired by the
patient or family. Often times in hospitals, the default is to treat and perform intensive
procedures in attempts to prevent the death of a patient. With advanced care planning and
integration of a palliative care team, patients can decide how much treatment they want and at
what point they prefer to opt out of treatment. Promoting policy solutions to address this problem
is essential to reducing EOL spending and improving quality of care for the aging population.
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Promoting the policy solution
As mentioned above, Medicare beneficiaries who have Medicare Part A should be
eligible for hospice benefits if they are certified by a physician as having an advanced or latestage, progressive or degenerative chronic illness. Medicare should also compensate physicians
or interdisciplinary teams for conducting advanced care planning with patients. In order to
advance the policy recommendation for CMS to revise the hospice benefit and payment system,
the MEDPAC commissioners must first vote on the MEDPAC recommendations. The
Commission chairman, Glenn Hackbarth, and the vice chairman, Michael Chernew, may have
influence over the opinions of the Commission’s 17 members.
Once MEDPAC publishes a recommendation, a representative should introduce a bill to
Congress that addresses modifications to the Medicare hospice benefits. The bill should be
introduced during a lame duck period between November and the inauguration of officials early
the next year, and with little fanfare in order to achieve bipartisan support. According to Mitchell
& Washington (2014), members of Congress are three to four percent less likely to vote along
party lines during lame duck sessions and more likely to vote for general interest. The MEDPAC
recommendations will serve as strong evidence for support of the bill. Building political support
among stakeholders and advocates is monumental for pushing the policy solution forward.

Building political will
Key health advocates can play an important role in promoting the bill and building
political support. Organizations such as the Robert Wood Johnson Foundation, American
Medical Association, AARP, the Center to Advance Palliative Care (CAPC) and the National
Hospice and Palliative Care Organization (NHPCO) should provide leadership in making the
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case to update the hospice payment system to Rep. Kevin Brady, the chairman of the House
Committee on Ways and Means Subcommittee on Health. Part of the rationale for proposed
changes was recently stated by Alice Rivlin, an economist and former U.S. Federal Reserve
official in her May 2013 testimony before the House Committee on Ways and Means
Subcommittee on Health. Ms. Rivlin stated:
“Why reform Medicare? The main reason for reforming Medicare is not that the program
is the principal driver of future federal spending increases, although it is. The main reason
is not that Medicare beneficiaries could be receiving much better coordinated and more
effective care, although they could. The most important reason is that Medicare is big
enough to move the whole American health delivery system away from fee-for-service
reimbursement, which rewards volume of services, toward new delivery structures, which
reward quality and value. Medicare can lead a revolution in health care delivery that will
give all Americans better health care at sustainable cost (Rivlin, 2013)”
Rivlin’s testimony adds support to the effort to modify the Medicare hospice benefit to provide
better care options to those with chronic disease. Other federal partners that may support the bill
include the Administration of Aging, the Agency for Health Resources and Quality, and the
Senate Commission on Long-Term Care, which issued detailed recommendations on the ways to
strengthen supports for family caregivers. Advocates of passing legislation should lobby
representatives in the House Committee on Ways and Means Subcommittee on Health months
prior to the introduction of the bill so that once a policy window opens, swift action can be taken
to introduce and pass the bill.
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PROMOTING TRAINING & CREDENTIALING
Advocating for enhanced training and credentialing of physicians on palliative care, EOL
care, and advanced care planning involves many stakeholders. The Accreditation Council on
Graduate Medical Education needs to require palliative care education and clinical experience in
programs for all specialties responsible for managing advanced serious illness (including primary
care clinicians). For this to happen, there needs to be support from the following member
organizations: the American Board of Medical Specialist, American Hospital Association,
American Medical Association, Association of American Medical Colleges, and the Council of
Medical Specialty Societies. The Liaison Committee on Medical Education requires accredited
U.S. medical schools to teach EOL care but the requirement is vague and does not specifically
mention palliative care and is not rigorously enforced through specific standards (IOM, 2014).
Directors of the major medical associations need to urge the committee to clarify and specify this
accreditation requirement.
Other stakeholders include the American Board of Hospice and Palliative Medicine
which certifies physicians seeking to demonstrate competence in the palliative care field.
Questions on EOL and palliative care need to be included on the U.S. Medical Licensing
Examination which is a professional exam sponsored by the Federation of State Medical Boards
(FSMB) and the National Board of Medical Examiners (NBME). Top leaders from CAPC and
the NHPCO need to meet with the heads of FSMB and NBME to emphasize the importance of
testing students on these healthcare issues.
Furthermore, Schools of Public Health should include EOL care in public health courses
which can help lead future health care administrators and policy makers to incorporate principles
of palliative care into health care systems. It is important to promote cross-collaboration and
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coordination among the various educational institutions, credentialing bodies and accrediting
boards to ensure a cohesive and integrated approach to improving palliative care knowledge
among health professionals.
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CONCLUSION
As the U.S. population continues to get older and suffer from multiple chronic conditions,
millions of people are going to require long-term care. Palliative care provides important
physical, psychosocial, and spiritual services, as well as pain management, to provide comfort
and quality of life to those at the end of their life or continuing curative treatment. Most people,
when given an option, would choose to receive palliative or EOL care in the familial
surroundings of their own home. In the next decades, palliative care is going to grow
substantially in the United States. Healthcare spending is also going to continue to increase
among the elderly and sick. Ensuring affordable and timely home-based palliative care to this
population is a critical step in reducing healthcare costs and improving quality of life.
Research shows that home-based palliative care is clinically effective, cost-effective and
increases patient and family satisfaction. Recommendations that will help remove barriers to care
include revising the Medicare hospice benefit to have less restrictive eligibility for home-based
care, providing incentives to healthcare providers for discussing and integrating palliative care,
and systematically training and educating health professionals on palliative care issues. There are
successful programs and models that public and private healthcare systems can model their own
programs after, document the results, and build the evidence base for home-based palliative care.
The adoption of recommended policies will require a well-planned advocacy strategy that
engages key stakeholders and target key constituencies and policymakers. As noted above, this
strategy should include an established policy framework that is focused on communicating the
problem effectively, promoting thoughtful and impactful policy solutions, and implementing
approaches to build political will. It is imperative that improvements in quality of palliative care
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and access to care are made so that all Americans, regardless of their financial status or medical
prognosis, receive the highest quality care possible.
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LIMITATIONS
While this article describes important information related to the clinical effectiveness,
cost-effectiveness and quality of life through home-based palliative care, there are a few
limitations that are important to address. Many of the articles lacked the strength of a randomized
control design and also lacked generalizability due to the specific settings where each study took
place. Additional research should be done with a strong study design to further compare homebased palliative care and non-home based palliative care in the United States. More research
should also be done to compare different models of home-palliative care and determine which
ones work most effectively and efficiently.
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APPENDIX: Policy Brief

Addressing End-of-Life Care in America:
The Opportunity for Home-Based Palliative Care
The problem of America’s aging population and end-of-life care
By 2050, 27 million people will need some type of long-term care service, most of whom
will have multiple chronic diseases (Giovanni, 2012). Longer life spans and aging baby boomers
will double the population of Americans aged 65 years or older during the next 25 years to about
72 million (CDC, 2013). Since two out of every three older Americans have multiple chronic
conditions, long-term care and end-of-life (EOL) care is going to continue growing as a
significant healthcare burden (CDC, 2013).
Treating patients with advanced illness at the end of life is costly and complex. Palliative
care, particularly home-based palliative care, can help to reduce healthcare costs at the end of
life. Palliative care is not solely for those who are dying, but for anyone whose goals are to
alleviate suffering and improve their quality of life, including those at the end of their life.
Currently, Medicare beneficiaries must choose between receiving treatment and receiving
palliative care. Therefore many people who could benefit from quality palliative care are not
receiving it due to choosing treatment. The need for palliative care is going to grow substantially
in the next decades and there is a major opportunity for palliative services in the United States to
be offered in the patient’s home. Palliative care is an essential service that should be accessible
and affordable to anyone who needs pain management and supportive care while living with
chronic conditions or other debilitating diseases.
Benefits of home-based palliative care
Evidence shows that home-based palliative care compared to palliative care in other
environments may result in fewer hospitalizations, fewer hospital days, fewer ED visits, and
fewer physician office visits (Lukas et. al. 2013, Brumley et. al. 2003 & 2007, Alonso-Babarro
et. al. 2013). Home-based palliative care also reduces the likelihood of readmission to a hospital
within 30 days (Ranganathan et. al. 2013) and increases the likelihood of completing an
advanced directive (Kerr et. al. 2014). Completing advanced directives improves the chance that
patients will receive life-saving care, or not receive care if desired, in times when they are unable
to speak for themselves.
Home-based palliative care has shown to be cost-effective and result in lowered spending
at a healthcare system and an individual level (Lukas et. al 2013, Hughes & Smith 2014,
Morrison et. al. 2008, Brumley et. al. 2003 & 2007, Guerriere et. al. 2010, Klinger et. al. 2013).
Patients in home-based palliative care are more likely to die in their own home, which is the
preference for a majority of people (Brumley et. al. 2003 & 2007, Alonso-Babarro et. al. 2013,
Shepperd et. al. 2011, Gomes et. al., 2013). Furthermore, home-based care patients and their
families report high levels of quality of life and satisfaction with their care (Brumley et. al. 2003
& 2007, Miyashita et. al. 2008, Guerriere et. al. 2013, Thomas et. al. 2010).
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Barriers to home-based palliative care
Many barriers prevent affordable and timely access to palliative care. A primary obstacle
is the financial burden for patients since many insurers, public and private, do not cover homebased palliative care. For instance, Medicare, one of the nation’s largest health insurers, only
provides the hospice benefit as an EOL option for patients. The current Medicare hospice benefit
only covers palliative and support services for patients designated to have a terminal illness and a
life expectancy of six months or less (CMS, 2013). By electing to receive the benefit, patients
forfeit any conventional treatment for the condition. This may feel to the patient that they are
“giving up” or resigning themselves to death.
A barrier related to getting timely access to palliative care is physicians and other
healthcare staff not initiating conversations around palliative care or EOL issues. This may be
due to the lack of incentives offered to healthcare professionals to initiate EOL conversations and
a lack of education around palliative care and when to discuss the topic. Doctors may feel that
they do not have enough time, resources, or knowledge to have these types of discussions with
their patients and therefore do not initiate the conversation until it is too late to have any valuable
impact.
Recommendations to limit barriers
1. Medicare benefit should include home-based palliative care without the requirement to
forego treatment
Medicare should cover home-based palliative care similarly to the way Medicare covers
hospice benefits but without the requirement to be terminally ill, have six months or less to live,
and to forego treatment. Palliative care should be available for those patients who wish to receive
care at home, but may also want to continue getting life-saving treatment. The current Medicare
hospice model does not address patients with multiple chronic conditions and ambiguous
prognoses. Providing palliative care earlier in the course of disease leads to better health
outcomes, higher satisfaction with care and reductions in healthcare costs (California HealthCare
Foundation, 2013). There is also considerable value in the simultaneous delivery of palliative
and curative care.
If Medicare included a benefit for home-based palliative care that did not require terminal
illness and the choice to forego treatment, many more people would benefit from improved
quality of life through palliative care and healthcare costs may be reduced. Medicare is already
spending about $15 billion on hospice a year and 34.5 percent of the hospice patients receive a
week or less of care (NHPCO, 2015). If home-based palliative care was offered to those same
patients earlier in their illness trajectory, costs could potentially be avoided by reducing
unnecessary care and managing high-need, “at risk” patients.
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2. Compensation to healthcare providers for discussing and integrating palliative care
The 2014 Institute of Medicine report, “Dying in America,” was released by a committee
of 21 experts that calls the U.S. EOL care system, a large part of which is palliative care,
“broken” and recommends several ways to improve care. One of the recommendations is
reimbursing providers to discuss palliative care and advance planning with their patients.
Incentives under fee-for-service Medicare result in increased use of medical services and late
enrollment in hospice, which can jeopardize the quality of EOL care and add to costs.
Incentivizing provisions of comprehensive palliative care and discouraging the use of costly and
unnecessary medical procedures can improve patient outcomes and reduce healthcare costs
(IOM, 2014).
The 2013 MEDPAC report also recommends a Medicare payment to compensate
physicians or interdisciplinary teams for voluntary advanced care planning. Providing
compensation to physicians and other healthcare providers for discussing palliative care options
and coordinating care would increase the number of patients who understand their care and
treatment options. Over time, the savings to Medicare due to reduced unnecessary spending
would help offset the cost of Medicare-financed incentives to healthcare providers. Federal or
state governments could subsidize incentives for private practice physicians contingent on
meeting quality standards.
3. Better training for health professionals on palliative care topics
There needs to be improved training of health professionals on issues like patientcentered care and palliative care as a longer term approach in improving care for patients with
advanced illness. According to the 2014 MEDPAC report, very short hospice stays are still
common which indicates that patients enter hospice in the last week or so of their life, unable to
receive the full benefit of palliative care. This may be due to physicians’ reluctance to have
conversations about hospice or death, difficulty in some patients and families to accept death,
and financial incentives in the fee-for-service system which value volume over quality
(MEDPAC, 2014). The IOM report (2014) recommends improving palliative care training
among all physicians. Educational institutions, credentialing bodies, accrediting boards, state
regulatory agencies and healthcare delivery organizations should establish appropriate training,
certification and licensure requirements to strengthen palliative care knowledge and skills of all
physicians who care for patients with advanced illness (IOM, 2014). Training of healthcare
professionals needs to emphasize high-quality care and comfort of the patient, including homebased palliative care options and advanced care planning. Acknowledging advanced illness and
mortality provides an opportunity to deliver high standards of care, grounded in choice and
responsiveness to needs for both the patient and their family.
When palliative care is taught, results can be impressive. A systematic review by BickelSwenson (2007) found that EOL educational curricula and clinical training found in a wide range
of formats improved the competency of medical students. Authors found a 23 percent
improvement in knowledge, a 56 percent improvement in feelings of competence, and a 29
percent decrease in concerns. George Washington University includes a standardized patient case
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on palliative care and a course on medical interviewing and decision making. The University of
Rochester includes content on advance care planning, chronic pain management, and discussion
of treatment goals. The Association of American Medical Colleges is in collaboration with the
Coalition to Transform Advanced Care to identify relevant core competencies.
The time to act is now
The aging of the American population is quickly expanding the healthcare burden, in
large part by the 66 percent of older adults who have multiple chronic conditions. Treating
advanced illness and chronic conditions in the older population is complex and expensive.
Medicare spending is expected to increase from $555 billion in 2011 to $903 billion in 2020. As
the U.S. healthcare system struggles to keep up with the demand for care, there will be an
increasing need for high-quality palliative care in all settings, but particularly home-based
settings. Patients and their families should have the choice to use home-based palliative care
when it is available, without the burden of financial or accessibility barriers. Providing this
home-based option will greatly alleviate the strain on inpatient settings and will reduce hospital
and patient costs. An approach toward high-quality care and coordination and away from overtreating or inappropriately treating patients will improve quality of life as well as reduce
unnecessary medical costs. It is imperative that improvements in quality of palliative care and
access to care are made so that all Americans, regardless of their financial status or medical
prognosis, receive the highest quality care possible.
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